After retroviral infection of a permissive cell, the viral RNA is reverse-transcribed to make a DNA copy of the viral genome. Integration of this DNA copy into the host genome is a necessary step for efficient viral replication. We have developed a cell-free system for integration of exogenous mini-retroviral DNA. The termini of this linear mini-Moloney murine leukemia virus (MoMLV) DNA are designed to mimic the ends of authentic unintegrated MoMLV DNA. The viral proteins required for integration can be provided either as a cytoplasmic extract of MoMLV-infected NIH 3T3 cells or as disrupted MoMLV particles. Phage A DNA serves as the target for integration. Genetic markers present on the mini-MoMLV DNA enable integration events to be detected, and the recombinants recovered, by selection in Escherichia coli. Integration, which occurs at heterogeneous locations in the target DNA, is absolutely dependent on the presence of a source of viral proteins and a divalent cation in the reaction mixture. The fidelity of the integration reaction was confimed by sequencing the junctions between the integrated MoMLV DNA and adjacent A DNA sequence. In each case, as expected for authentic MoMLV DNA integration, a 4-base-pair duplication of target DNA sequence flanked the integrated MoMLV DNA.
Integration of a DNA copy of a retroviral genome into a chromosome of the host cell is an essential step for efficient viral replication (for a recent review, see ref. 1) . The integrated viral DNA may be transcribed and the resulting RNA serves as both mRNA for translation of viral proteins and as the viral genome. Virions bud from the cell surface and, after infection of a permissive cell, the viral RNA is reverse-transcribed and the resulting DNA copy can be integrated into the host genome, completing the viral replication cycle.
The Moloney murine leukemia virus (MoMLV) virion particle has a basic structure that is typical of mammalian retroviruses (1) (2) (3) . It consists of a core enclosed by an envelope derived from the host cell membrane. The envelope contains viral glycoproteins that recognize specific cell surface receptors. The core includes copies ofthe viral RNA and the products of the viral gag and poi genes. The MoMLV poi gene products, which are necessary for reverse transcription and integration, are generated by proteolytic processing of a gag-pol precursor. The central domain of the poi product possesses the reverse transcriptase activity (4) . Mutations in the smaller C-terminal domain of the poi product, which is cleaved from the reverse transcriptase domain as the p46 IN protein (5) , abolish integration (4) .
The linear DNA product of MoMLV reverse transcription remains associated with proteins as a high molecular weight nucleoprotein complex in the cytoplasm of infected cells (6, 7) . This core particle may contain all the protein factors necessary for integration of the endogenous viral DNA. A cell-free system has been devised for integration of the endogenous viral DNA associated with the core particles (6) , and this system has been exploited to analyze the structure of the integration intermediate (7) . This intermediate, generated by integration of endogenous viral DNA into a target DNA, results from joining of the 3' ends of viral DNA, from which 2 bases have been lost at each 3' end, to the 5' ends of a double-strand cut made in the target DNA. The 5' ends of the viral DNA, which are full-length, remain unjoined in this intermediate, and a subsequent DNA repair step is necessary to complete the integration process. The unintegrated viral DNA isolated from core particles is homogeneously fulllength at its 5' ends, but a significant fraction is shorter by 2 nucleotides at its 3' ends (7) . The structure of the integration intermediate strongly suggests that this species of viral DNA, which is full-length at its 5' ends but recessed by 2 bases at its 3' ends, is the immediate precursor for integration. A 4-base staggered cleavage of the target DNA is inferred from the 4-base-pair duplication of target DNA sequence that is known to occur at the site of MoMLV integration (8) . These DNA cleavage and joining steps of the MoMLV DNA integration reaction are strikingly similar to the transposition mechanism of a prokaryotic transposon, bacteriophage Mu. Transposition of Mu also involves joining of the 3' ends of the element to the 5' ends of a staggered cut made in a target DNA, to form an integration intermediate in which the 5' ends of the element remain unjoined (9) . The central mechanistic steps of these DNA integration reactions may be highly conserved among diverse mobile genetic elements from prokaryotes to higher eukaryotes.
Of critical importance to understanding the mechanism of MoMLV integration is identification of the protein factors involved. This task requires, as an assay, a cell-free integration system in which the necessary protein factors can be added to the reaction mixture separately from the DNA substrate to be integrated. Here Reaction mixtures with virus particles as the source of viral proteins were as described above, except for the following changes: Nonidet P-40 was included at 0.05%, dithiothreitol was increased to 10 mM, and the 30°C incubation was decreased to 30 min. All reaction components, with the exception of uninfected cell extract, virus particles, and PEG, were mixed in a volume of 30 ,l and chilled on ice. The cell extract (90 ,ul) was then added. Virus particles were diluted to a protein concentration of -0.1 mg/ml in 0.3 M KCI/25 mM Tris, pH 7.4/0.05% Nonidet P-40/1 mM dithiothreitol, and 5 ,ul of this was added to the reaction mixture after addition of the cell extract. After preincubation on ice for 1 hr, 25 ,ul of 30% PEG was added and incubation was continued for a further 30 min at 30°C.
Reaction with infected-cell extracts or virus particles were terminated by addition of 16 1.d of Pronase (Calbiochem) at 5 mg/ml in 250 mM EDTA, 2 /4 of 20% NaDodSO4, and 232 ul of H20. After incubation at 370C for at least 2 hr, 100 /ul of 1.5 M NaOAc (pH 7) was added and the samples were gently extracted twice with buffer-saturated phenol and twice with chloroform. The DNA was precipitated with ethanol, washed twice with 70% ethanol, dried, and resuspended overnight in 4 /ul of 1 mM Tris, pH 8/0.05 mM EDTA.
Scoring of Mini-MoMLV Integration Events. The resuspended DNA was packaged in an in vitro A packaging extract (Gigapack Gold, Stratagene) and E. coli strain MK382 was infected with the phage. MK382 was grown to an OD600 of 1.0 in tryptone broth supplemented with 10 mM MgSO4 and 0.2% (wt/vol) maltose. Cells were collected by centrifugation and resuspended in half their original volume in 10 mM MgSO4. Half of each packaging reaction mixture was added to a 2-ml aliquot of the resuspended cells, which was then incubated for 20 min at 30'C, with shaking, to allow adsorption of the phage. The cells were then gently pelleted by centrifugation and resuspended in 2 ml of SOC medium (BRL). Incubation was continued for a further 90 min at 30°C, with shaking, and the cells were then plated on Luria agar plates containing ampicillin (50 ,ug/ml) and tetracycline (15 jg/ml). Colonies were counted after about 20 hr of incubation at 30°C. Phage titers were determined by plating serial dilutions ofpackaging mixtures onto lawns of E. coli strain JM109.
Integration of Endogenous MoMLV DNA. Reaction conditions and visualization of the products by gel electrophoresis were as described (7).
RESULTS
Integration of Mini-MoMLV DNA in a Cell-Free Reaction. A cell-free system in which exogenously added viral DNA can be correctly integrated into a target DNA, when provided with the appropriate protein factors, is necessary for detailed analysis of the retroviral DNA integration mechanism. We have developed such a system for MoMLV. A mini-MoMLV plasmid was constructed, such that cleavage of this plasmid by restriction endonuclease Nde I generates a linear miniMoMLV DNA substrate for integration (Fig. 1) . The end structure of this mini-MoMLV DNA mimics that of the unintegrated viral DNA within the cytoplasm of MoMLVinfected cells. The termini comprise the short inverted repeat sequences at the ends of unintegrated endogenous MoMLV DNA that are known to be essential for integration (11, 12) , and are presumably recognized by a viral "integrase" protein. The mini-MoMLV DNA is shorter by 2 nucleotides at each of its 3' ends than the expected full-length product of reverse transcription and thus corresponds to the form of MoMLV DNA that is likely to be the immediate precursor for integration (7) . It carries the ampicillin-and tetracyclineresistance genes of pBR322 and also the pBR322 origin of replication.
For initial experiments, a cytoplasmic extract of MoMLVinfected NIH 3T3 cells provided the protein factors needed for integration. The extract was first fractioned by sizeexclusion chromatography on a column of Sephacryl S400 (7), and the excluded peak, which includes the viral core particles and is competent for integration of the viral DNA copy within these particles, was retained. Phage A DNA was included in the reaction mixture as a target DNA for integration. After incubation, the DNA was deproteinized, the A DNA was packaged in vitro, and a A lysogen strain of E. coli was infected with the resulting phage. Recombinants were selected by plating the infected cells on agar plates containing ampicillin and tetracycline; A DNA into which mini-MoMLV DNA has integrated replicates as a plasmid in A lysogens of E. coli, thus conferring resistance to these two antibiotics.
The above strategy, detailed in Materials and Methods, does indeed yield ampicillin/tetracycline-resistant (AmpR (11) . The mini-MoMLV DNA also carries the replication origin and the ampicillin-and tetracycline-resistance genes ofpBR322, enabling the selection of recombinants in E. coli. TetR) colonies. Colonies are not recovered when MoMLVinfected cell extract is omitted from the reaction mixture, demonstrating that the integration events occur in the reaction mixture itself, rather than during the subsequent step of in vitro A packaging, which is necessary for the detection of recombinants. To test the fidelity of the integration reaction, plasmid DNA was analyzed from 30 of the isolates. Restriction mapping revealed that all 30 contained a A-size plasmid, into which a copy of mini-MoMLV had integrated at heterogeneous locations. The junctions between mini-MoMLV DNA and adjacent A DNA were sequenced for 8 of the recombinants (Fig. 2) . In each case, the integrated miniMoMLV DNA terminates correctly at both ends to give a viral sequence 5'-TG ..... CA-3' and is flanked by a 4-base-pair directly repeated duplication of target DNA sequence at the site ofintegration, features that are characteristic ofauthentic MoMLV DNA integration.
Elution Profile of Integration Activity from Sephacryl S-400. The bulk of the viral DNA in cytoplasmic extracts of MoMLV-infected cells exists as a high molecular weight nucleoprotein complex (6, 7) that is eluted from Sephacryl S-400 in the excluded peak (7) . Since the viral DNA associated with the core particles in this fraction is efficiently integrated into a target DNA in vitro (6, 7) , each viral DNA copy may be associated, in the core particle, with all the protein factors required for integration. One might therefore expect that this excluded fraction would also contain most of the activity for integration of our exogenously added mini- MoMLV DNA. However, when equal volumes of the Sephacryl S-400 fractions were assayed for their activity to integrate mini-MoMLV, the peak of integration activity (Fig.  3A) was significantly shifted from the excluded-volume peak. In fact, gel electrophoresis and Southern blotting of the viral DNA within each fraction (Fig. 3B) revealed that fraction 16, the peak of activity for integration of mini-MoMLV DNA, contained very little viral DNA; most of the viral DNA was found with the excluded peak (fractions 12 and 13), as expected. When the same fractions were assayed for integration of the endogenous viral DNA copies, the quantity of integrated product generated was greatest for the excluded fractions, which contained most of the viral core particles (Fig. 3C) .
If we assume that at least one of the protein factors required for integration of mini-MoMLV DNA is provided by the viral core particles, the results presented in Fig. 3 suggest that an additional protein factor is necessary for efficient recovery of integrated mini-MoMLV products and that these factors are partially resolved by chromatography on Sephacryl S-400. This conclusion is supported by the result of assaying mixed fractions. An almost 10-fold increase in apparent activity was observed when fractions 12 and 17 of Fig. 2 above for integration reactions with extracts of MoMLVinfected cells.
The requirements for this reaction are summarized in Table  1 . Integration events are absolutely dependent on the presence of disrupted MoMLV particles and a divalent cation in the reaction mixture. Although some integration products were recovered when MoMLV particles were the sole source of protein factors, the efficiency was increased at least 50-fold by inclusion of a cytoplasmic cell extract (trailing edge of the excluded peak from Sephacryl S-400) of uninfected (Table 1) or MoMLV-infected (data not shown) NIH 3T3 cells in the reaction mixture. The stimulatory activity of the cytoplasmic extract was abolished by heating it at 600C for 15 min prior to addition to the reaction mixture, suggesting that a protein factor is responsible. Omission of dimethyl sulfoxide reduced the recovery of AmpRTetR colonies by a factor > 10; however, the recovery of packageable A DNA was also greatly decreased in these reactions. Dimethyl The standard reaction conditions, with virus particles as the source of viral proteins, are described in Materials and Methods. Typical standard reactions yielded several hundred colonies. This efficiency can be increased at least 10-fold by increasing the concentration of viral protein in the reaction mixture (data not shown). The heattreated cytoplasmic extract was incubated at 60'C for 15 min and chilled on ice before addition to the reaction mixture. The total number ofA phage used for infection was determined by plating serial dilutions of the packaged DNA on lawns ofJM109. Data were pooled from a duplicte set of experiments.
sulfoxide routinely stimulated the reaction severalfold, even when colony counts were normalized to correct for differences in the recovery of packageable A DNA (data not shown). No significant variation in the recovery of packageable A DNA was observed among the other reaction conditions tested (Table 1) .
Other Potential Mini-MoMLV DNA Substrates. The Mo-MLV DNA that becomes joined to a target DNA in the integration intermediate is 2 bases shorter at each of its 3' ends than the full-length product of reverse transcription (7) .
It is likely that this shorter species is generated from full-length viral DNA by nucleolytic cleavage of 2 bases from each 3' end prior to cleavage of the target DNA. A virusencoded polypeptide that includes the product of the IN region of the pol gene is a strong candidate for such an activity.
We tested two potential mini-MoMLV substrates for which specific endonucleolytic cleavage would be a prerequisite for correct integration. One was a circular mini-MoMLV containing the circle-junction sequence that would be formed by end-to-end ligation of full-length MoMLV DNA. The other potential substrate, which was linear and blunt-ended, was made by Stu I digestion of a plasmid in which the Nde I restriction site of pMK471 was replaced by a Stu I site. Correct integration was not detected with either of these substrates (see Discussion).
DISCUSSION
Correct Integration of Exogenously Added Mini-MoMLV DNA in a Cell-Free Reaction. A double-stranded MoMLV DNA copy, made by reverse transcription of viral RNA within the cytoplasm of an infected cell, remains part ofa high molecular weight nucleoprotein complex that probably contains all the protein factors necessary of its integration (6, 7) . Correct integration of exogenously added mini-MoMLV DNA in vitro demonstrates that the viral integration apparatus can transfer from the endogenous viral DNA copy, to promote integration of an exogenous mini-MoMLV DNA. Disrupted MoMLV particles are also a source of the active form of viral protein(s) necessary for integration. It remains to be determined which viral polypeptide(s) is directly involved in the integration reaction. Genetic evidence strongly implicates the MoMLV IN protein (4) . However, it is not known if the p46 IN cleavage product itself, or another form, such as a higher molecular weight precursor, is the active species. It is also possible that other viral proteins are needed for integration that have not been identified genetically because they are essential for other viral functions. The Proc. Natl. Acad. Sci. USA 86 (1989) I cell-free system for integration of exogenously added miniMoMLV DNA provides a direct biochemical assay that can be used to identify and purify the viral proteins involved in the integration reaction.
Possible Involvement of Cellular Proteins in MoMLV Integration. The amount of integration products recovered is significantly increased by inclusion of a cytoplasmic extract of NIH 3T3 cells in the reaction mixture. This activity is heat-labile, suggesting that a protein is responsible. One possible interpretation is that a cellular protein is directly involved in the integration reaction itself, either as a stimulatory factor or as an essential factor that is provided in limiting quantity by the virus particles. However, we emphasize that since our reaction system is undefined, and we rely on a subsequent step of A packaging to detect recombinants, the role of this apparent stimulatory activity could equally well be indirect. Protection of the DNA substrates against nucleolytic attack, which is one of the more obvious of such possibilities, does not seem to account for the phenomenon: we have not detected any increase in the stability of the DNA substrates in the presence of cytoplasmic extract, as judged either by the integrity of the ends of the mini-MoMLV DNA after incubation or by recovery of packageable A DNA (data not shown).
Generation of the 2-Base Recess at the 3' Ends of MoMLV DNA. The DNA precursor for integration is shorter by 2 bases at its 3' ends than the full-length product of reverse transcription. Either this species comprises a subpopulation of viral DNA in which these bases were never synthesized or, more likely, the product of reverse transcription is uniformly full-length and a virus-encoded nuclease activity subsequently cleaves 2 bases from each 3' end. Such an endonuclease activity has been directly, or indirectly, demonstrated for some other retroviruses. The pp32 cleavage product ofthe avian sarcoma and leukosis virus pol gene products have an endonuclease activity that preferentially cleaves between the terminal CA and TT nucleotides under appropriate reaction conditions (13) (14) (15) . For avian spleen necrosis virus, an internal circle-junction sequence can act as a site for correct integration into a target DNA (16), implying specific cleavage at this site. A corresponding endonuclease activity has not been detected for MoMLV. However, some mutations in the IN coding sequence of MoMLV result in viruses that, after infection, exclusively produce viral DNA that is full-length and blunt (M. Roth, P. Schwartzberg, and S. Goff, personal communication). This strongly argues that these mutations abolish an endonuclease activity normally associated with a protein encoded by the IN coding sequence but does not entirely exclude the alternative possibility that this polypeptide is involved in preventing addition of these bases.
Our failure to detect correct integration of mini-MoMLV DNA substrates that require specific endonucleolytic cleavage should not be regarded as evidence that MoMLV integration does not normally involve such an activity. These mini-MoMLV constructions may not be good substrates for this hypothetical endonuclease because their end structures are not identical to full-length blunt MoMLV DNA, although they are very closely related. In one case, the terminal TT-3' is replaced by GG-3', and in the other construction, a pair of normal full-length terminal sequences is joined to form a circle junction. Another important consideration is that our reaction mixtures contain a large excess of mini-MoMLV DNA over putative integrase proteins, such as IN. Therefore, correctly cleaved substrate would be expected to constitute only a minor fraction of the mini-MoMLV in the reaction mixture, especially if cleavage at each 3' end occurs independently.
Analysis of the structure of the integration intermediate (7) strongly suggested that the linear form ofMoMLV DNA from which 2 bases have been lost at each 3' end, rather than the less abundant circular species, is the immediate precursor for integration. This conclusion is strengthened by the successful integration of mini-MoMLV DNA that mimics this linear form and by our failure to detect integration with the circular mini-MoMLV plasmid.
Potential Improvement of the Mini-MoMLV Integration Assay. Many basic questions concerning the molecular mechanism of retroviral DNA integration remain to be addressed. Of particular importance is identification of the proteins involved and determination of their full and partial biochemical activities. Our mini-MoMLV DNA integration assay provides a tool that may be used to identify the necessary viral polypeptide(s) and any cellular proteins that may be involved in the integration reaction. At present, we must rely on the highly sensitive, but laborious, assay step of in vitro A packaging, because the protein factors necessary for integration are limiting. Once identified, these proteins can be cloned, expressed in much larger quantities than are presently available to us, and purified. It should then be possible to detect the integration products directly by a gel electrophoresis assay. The development of a defined retroviral DNA integration system and a simple assay method is a necessary step for detailed biochemical and structural analysis of retroviral DNA integration. In addition, such a system would provide a very simple and economical means to screen for specific inhibitors of this critical step in the retroviral replication cycle.
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